These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10502205)

  • 1. The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival.
    Lucas C; Stevenson LW; Johnson W; Hartley H; Hamilton MA; Walden J; Lem V; Eagen-Bengsten E
    Am Heart J; 1999 Oct; 138(4 Pt 1):618-24. PubMed ID: 10502205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.
    Wessler BS; Kramer DG; Kelly JL; Trikalinos TA; Kent DM; Konstam MA; Udelson JE
    Circ Heart Fail; 2011 Sep; 4(5):578-88. PubMed ID: 21705485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A shuttle walk test for assessment of functional capacity in chronic heart failure.
    Morales FJ; Martínez A; Méndez M; Agarrado A; Ortega F; Fernández-Guerra J; Montemayor T; Burgos J
    Am Heart J; 1999 Aug; 138(2 Pt 1):291-8. PubMed ID: 10426841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 6-minute walk test does not reliably detect changes in functional capacity of patients awaiting cardiac transplantation.
    Cheetham C; Taylor R; Burke V; O'Driscoll G; Green DJ
    J Heart Lung Transplant; 2005 Jul; 24(7):848-53. PubMed ID: 15982612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cardiopulmonary exercise test protocol and criterion to determine maximal oxygen uptake in chronic heart failure.
    Bowen TS; Cannon DT; Begg G; Baliga V; Witte KK; Rossiter HB
    J Appl Physiol (1985); 2012 Aug; 113(3):451-8. PubMed ID: 22653993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure.
    Pulz C; Diniz RV; Alves AN; Tebexreni AS; Carvalho AC; de Paola AA; Almeida DR
    Can J Cardiol; 2008 Feb; 24(2):131-5. PubMed ID: 18273487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-minute walk work for assessment of functional capacity in patients with COPD.
    Carter R; Holiday DB; Nwasuruba C; Stocks J; Grothues C; Tiep B
    Chest; 2003 May; 123(5):1408-15. PubMed ID: 12740255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation.
    Kato TS; Collado E; Khawaja T; Kawano Y; Kim M; Farr M; Mancini DM; Schulze PC
    Circ Heart Fail; 2013 Jan; 6(1):6-14. PubMed ID: 23204059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Habitual activities and peak aerobic capacity in patients with asymptomatic and symptomatic left ventricular dysfunction.
    Mezzani A; Corrà U; Baroffio C; Bosimini E; Giannuzzi P
    Chest; 2000 May; 117(5):1291-9. PubMed ID: 10807813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability of the 6 minute walk in persons with fibromyalgia.
    King S; Wessel J; Bhambhani Y; Maikala R; Sholter D; Maksymowych W
    J Rheumatol; 1999 Oct; 26(10):2233-7. PubMed ID: 10529146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 6-min walk test in heart failure: is it a max or sub-maximum exercise test?
    Jehn M; Halle M; Schuster T; Hanssen H; Weis M; Koehler F; Schmidt-Trucksäss A
    Eur J Appl Physiol; 2009 Oct; 107(3):317-23. PubMed ID: 19618202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of age on aerobic capacity in heart failure patients under beta-blocker therapy: possible impact in clinical decision-making?
    Ciolac EG; Bocchi EA; Fernandes da Silva MM; Tavares AC; Teixeira-Neto IS; Guimarães GV
    Cardiol J; 2013; 20(6):655-61. PubMed ID: 24338544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.
    Florea VG; Henein MY; Anker SD; Francis DP; Chambers JS; Ponikowski P; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):146-53. PubMed ID: 10637088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The 6 minute walking test: a cost-effective alternative to spiro-ergometry in patients with chronic heart failure?].
    Haass M; Zugck C; Kübler W
    Z Kardiol; 2000 Feb; 89(2):72-80. PubMed ID: 10768274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure.
    Cahalin LP; Mathier MA; Semigran MJ; Dec GW; DiSalvo TG
    Chest; 1996 Aug; 110(2):325-32. PubMed ID: 8697828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of non-invasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure.
    Goda A; Lang CC; Williams P; Jones M; Farr MJ; Mancini DM
    Am J Cardiol; 2009 Dec; 104(11):1556-60. PubMed ID: 19932792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?
    Opasich C; Pinna GD; Mazza A; Febo O; Riccardi R; Riccardi PG; Capomolla S; Forni G; Cobelli F; Tavazzi L
    Eur Heart J; 2001 Mar; 22(6):488-96. PubMed ID: 11237544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular diastolic filling pattern predicts cardiopulmonary determinants of functional capacity in patients with congestive heart failure.
    Parthenakis FI; Kanoupakis EM; Kochiadakis GE; Skalidis EI; Mezilis NE; Simantirakis EN; Kanakaraki MK; Vardas PE
    Am Heart J; 2000 Aug; 140(2):338-44. PubMed ID: 10925352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2).
    Francis DP; Shamim W; Davies LC; Piepoli MF; Ponikowski P; Anker SD; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):154-61. PubMed ID: 10637089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.